Collegium Pharmaceutical (COLL) Operating Expenses (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Operating Expenses of $86.4 million for Q1 2026, up 14.16% year-over-year from $75.6 million in Q1 2025, and up 27.7% quarter-over-quarter from $67.6 million in Q4 2025.
Collegium Pharmaceutical (COLL) Operating Expenses (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Operating Expenses history runs 13 years deep, the most recent figure standing at $86.4 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 14.16% year-over-year to $86.4 million; the TTM figure through Mar 2026 stood at $294.3 million (up 22.08% YoY), while the FY2025 annual figure was $283.6 million, up 36.72% from the prior year.
- Operating Expenses for Q1 2026 stood at $86.4 million, up from $67.6 million in the prior quarter.
- The five-year high for Operating Expenses was $86.4 million in Q1 2026, with the low at $32.9 million in Q4 2023.
- The 5-year median for Operating Expenses is $52.8 million (2023), against an average of $53.7 million.
- Peak annual rise in Operating Expenses reached 82.68% in 2024, while the deepest fall reached 20.45% in 2024.
- Collegium Pharmaceutical's Operating Expenses stood at $38.0 million in 2022, then slipped by 13.38% to $32.9 million in 2023, then jumped by 82.68% to $60.2 million in 2024, then gained by 12.37% to $67.6 million in 2025, then climbed by 27.7% to $86.4 million in 2026.
- Business Quant data shows COLL's Operating Expenses at $86.4 million in Q1 2026, $67.6 million in Q4 2025, and $67.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.43 Mn | 740.11 Mn | 110.29 Mn | 106.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106.59 Mn |
| Mar 31, 2026 | 86.35 Mn |
| Dec 31, 2025 | 67.62 Mn |
| Sep 30, 2025 | 67.08 Mn |
| Jun 30, 2025 | 73.28 Mn |
| Mar 31, 2025 | 75.64 Mn |
| Dec 31, 2024 | 60.18 Mn |
| Sep 30, 2024 | 61.96 Mn |
| Jun 30, 2024 | 43.34 Mn |
| Mar 31, 2024 | 41.98 Mn |
| Dec 31, 2023 | 32.94 Mn |
| Sep 30, 2023 | 35.30 Mn |
| Jun 30, 2023 | 38.19 Mn |
| Mar 31, 2023 | 52.78 Mn |
| Dec 31, 2022 | 38.03 Mn |
| Sep 30, 2022 | 38.37 Mn |
| Jun 30, 2022 | 41.25 Mn |
| Mar 31, 2022 | 58.51 Mn |
| Dec 31, 2021 | 32.79 Mn |
| Sep 30, 2021 | 31.96 Mn |